Molecular Matrix, Inc.
Molecular Matrix, Inc. is dedicated to advancing biotechnology through innovation, providing solutions in bone regeneration, tissue engineering, and regenerative medicine. They develop advanced biomaterials, including proteoglycan mimics like Osteo-P® BGS, to support bone healing and repair. The company emphasizes research, development, and the application of cutting-edge technologies such as smart biomaterials, 3D and 4D printing, nanotechnology, and personalized implants to improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Molecular Matrix, Inc.
11121 Sun Center Drive, Suite C, Rancho Cordova, CA 95670
Products
Hyper-crosslinked carbohydrate polymer bone graft substitute
A non-mineralized, synthetic porous bone void filler made from a hyper-crosslinked carbohydrate polymer that is biocompatible, biodegradable, and osteoconductive; designed to support bone ingrowth and be resorbed as healing occurs.
Hyper-crosslinked carbohydrate polymer bone graft substitute
A non-mineralized, synthetic porous bone void filler made from a hyper-crosslinked carbohydrate polymer that is biocompatible, biodegradable, and osteoconductive; designed to support bone ingrowth and be resorbed as healing occurs.
Services
Manufacture and commercial supply of synthetic, non-mineralized biodegradable bone void fillers in multiple form factors for surgical use.
Collaborative R&D and participation in preclinical testing, technical presentations, and dissemination of study results at scientific meetings.
Manufacture and commercial supply of synthetic, non-mineralized biodegradable bone void fillers in multiple form factors for surgical use.
Collaborative R&D and participation in preclinical testing, technical presentations, and dissemination of study results at scientific meetings.
Expertise Areas
- Bone graft substitute development
- Biomaterials and scaffold engineering
- Tissue engineering and regenerative medicine
- Osteoimmunology and bone microenvironment research
Key Technologies
- Hyper-crosslinked carbohydrate polymer scaffolds
- Porous scaffold architecture with controlled pore size
- Biodegradable polymer biomaterials
- Osteoconductive scaffold materials
News & Updates
August 7, 2019 | Read more about the strategic partnership.
Osteo-P® BGS Market Launch
November 30, 2018 | Launch of the next-generation bone graft substitute.
December 29, 2017 | The company receives FDA clearance for its bone graft technology.
Discusses the role of proteoglycans in bone structure and the development of biomimetic materials like Osteo-P® BGS.
Explores the ideal characteristics of bone graft substitutes and their biological mechanisms.
August 7, 2019 | Read more about the strategic partnership.
Osteo-P® BGS Market Launch
November 30, 2018 | Launch of the next-generation bone graft substitute.
December 29, 2017 | The company receives FDA clearance for its bone graft technology.
Discusses the role of proteoglycans in bone structure and the development of biomimetic materials like Osteo-P® BGS.
Explores the ideal characteristics of bone graft substitutes and their biological mechanisms.